Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Scopus BioPharma Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −2 vs. Q1 2022
- Shares held
- 686.7K
- −321.9K (−31.9%) vs. Q1 2022
- Total value
- $293.0K
- −$400.0K (−57.7%) vs. Q1 2022
- New holders
- 3
- 4 more added
- Sold out
- 5
- 2 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $7.49K |
| Q3 2022 | 15 | $110.6K |
| Q2 2022 | 17 | $293.0K |
| Q1 2022 | 19 | $693.0K |
| Q4 2021 | 21 | $4.71M |
| Q3 2021 | 14 | $1.14M |
| Q2 2021 | 15 | $1.07M |
| Q1 2021 | 28 | $4.89M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Scopus BioPharma Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 217,078 | $93.0K | 0.00% | +13,273+6.5% | Added |
| Renaissance Technologies LLC | 130,852 | $56.0K | 0.00% | +18,329+16.3% | Added |
| M&R Capital Management Inc | 76,819 | $33.0K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 58,162 | $25.0K | 0.00% | +58,162 | New |
| Vanguard Group Inc | 54,649 | $24.0K | 0.00% | −309,792−85.0% | Reduced |
| Bridgeway Capital Management, LLC | 32,966 | $14.0K | 0.00% | −35,000−51.5% | Reduced |
| Tower Research Capital LLC (TRC) | 28,158 | $12.0K | 0.00% | +18,971+206.5% | Added |
| First Manhattan Co | 25,800 | $11.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 20,729 | $9.00K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 17,405 | $7.00K | 0.00% | +17,405 | New |
| Northern Trust Corp | 12,516 | $5.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Compagnie Lombard Odier SCmA | 4,360 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 89 | $0 | 0.00% | +7+8.5% | Added |
| UBS Group AG | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1,000 | $0 | 0.00% | +1,000 | New |
| BlackRock Inc. | 0 | $0 | 0.00% | −36,675−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −30,229−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,723−100.0% | Sold out |
| Moors & Cabot, Inc. | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −2,109−100.0% | Sold out |